Scientists at Israel’s Bar-Ilan University have found that malignant cells in hematologic cancer (leukemia, lymphoma, and multiple myeloma etc.), rely on a cytoskeletal protein, called WASp. Attacking WASp can destroy malignant cells without threatening healthy ones.

https://www.jpost.com/health-and-wellness/bar-ilan-u-team-develops-treatment-approach-for-hematologic-cancers-683190

https://pubmed.ncbi.nlm.nih.gov/25210148/